AMPLIFON | Stock ComparatorAMPLIFON
None
Overview
Sector
Medical Distribution
Strengths
- With an appreciation Potential of 65.80%, based on our fundamental analysis, it suggests the stock may be undervalued.
- Price to book ratio (2.33) is lower than the sector mean (35.33).
- EV/EBITDA (6.51) is lower than the sector mean (40.52).
- EV/EBIT (17.49) is lower than the sector mean.
- Price to free cash flow (7.84) is lower than the sector mean.
- Strong EBITDA Margin of 21.47%.
Weaknesses
- The company has high debt. Net Debt to EBITDA Ratio (1.99) is higher than the sector mean.
Key Financial Data
| Indicator | Value |
|---|
| PER | 25.4 |
| EV/EBITDA | 6.5 |
| Price/Free Cash Flow' | 7.8 |